EICHOR
● Recruiting
Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma Refractory · Sponsor: Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
About this study
The mail purpose of this study is to estimate the safety and the efficacy of anti-BCMA CAR- T cell immunotherapy for adults with relapsed or refractory multiple myeloma
This description comes directly from the study's public registry record.
Talk to the study team
Mikhail Uss, MD · +375291362230 · mikhail.uss@mail.ru
Always discuss trial participation with your own doctor first.
Locations (1)
| State Institution Minsk Scientific and Practical Center for Surgery, Transplantology, and Hematology | Minsk, Belarus | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07477912